(Q40610879)

22 September 2017

title

Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer (English)

1 reference

22 September 2017

1 reference

Shenep JL

1

1 reference

22 September 2017

Flynn PM

2

1 reference

22 September 2017

Baker DK

3

1 reference

22 September 2017

Hetherington SV

4

1 reference

22 September 2017

Hudson MM

5

1 reference

22 September 2017

Hughes WT

6

1 reference

22 September 2017

Patrick CC

7

1 reference

22 September 2017

Roberson PK

8

1 reference

22 September 2017

Sandlund JT

9

1 reference

22 September 2017

Santana VM

10

1 reference

22 September 2017

Sixbey JW

11

1 reference

22 September 2017

Slobod KS

12

1 reference

22 September 2017

language of work or name

English

0 references

publication date

8 December 2000

1 reference

Clinical Infectious Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

32

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

36-43

1 reference

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

22 September 2017

cites work

1 reference

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

21 January 2018

1 reference

Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient

21 January 2018

1 reference

Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospital

21 January 2018

1 reference

Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia

21 January 2018

1 reference

Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition

21 January 2018

1 reference

Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin

21 January 2018

1 reference

Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia

21 January 2018

1 reference

Early discharge of low-risk febrile neutropenic children and adolescents with cancer

21 January 2018

1 reference

Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study

21 January 2018

1 reference

The pharmacokinetic and bactericidal characteristics of oral cefixime

21 January 2018

1 reference

Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor

21 January 2018

1 reference

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

21 January 2018

1 reference

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

21 January 2018

1 reference

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.

21 January 2018

1 reference

Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics

21 January 2018

1 reference

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/317552

1 reference

22 September 2017

1 reference